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Introduction
60 million adults in United States have been diagnosed 
with diabetes, are currently undiagnosed with this dis-
ease, or have pre-diabetes [1]. Pre-diabetes is a condition 
in which blood glucose levels are higher than normal, 
but not high enough for a diagnosis of diabetes. Clini-
cally the range for a fasted blood glucose tests indicating 
pre-diabetes ranges from 100 mg/dL to 125 mg/dL, and 
may also be referred to as impaired glucose tolerance 
(IGT). Type II is the most common form affecting nearly 
95% of the U.S. diabetic population [2]. This translates 
to an alarming 9% prevalence of this disease among the 
adult population. Diabetes has long been recognized as 
the leading cause of blindness, renal abnormalities, and 
non-traumatic amputations [3]. Furthermore, the risk for 
death is twice as much for an individual with diabetes, 
than one without diabetes. Diabetes is the sixth leading 
cause of death and diabetes is often underreported as a 
cause of death [4]. Diabetes cost $132 billion, of which 
$40 billion were due to indirect causes such as disability, 
absenteeism, and premature mortality. 
Although genetics play a role in the development of type 
II diabetes, the environment, and one’s lifestyle con-
tribute to this process. The Center for Disease Control 
(CDC’s) Diabetes Program [5] says that as Americans, 
“we are eating ourselves into a diabetes epidemic”. Al-
most half of all that have been diagnosed with type II 
have also been diagnosed as obese  [6]. In the state of 
New York, 5.7% and 17.4% of the population had diabe-
tes and were obese respectively. In 2009, the prevalence 
increased to 8.9% and 24.6%, for diabetes and obesity 
respectively [7].
There exists a public health opportunity to promote initi-
atives that aim to modify eating habits, physical activity, 
and offer pre-diabetes screening programs to those who 
have one or more risk factors for diabetes. First and fore-
most, our aim should be to encourage healthy behavior 
as this is the most cost effective and sustainable method 
to reduce the diabetic crisis. The landmark results of the 
Diabetes Prevention Program, a 27 center randomized 
clinical trial across the United States [8], has shown that 
lifestyle changes have been shown to be more effective 
than medication [9] and extreme lifestyle interventions 
may reduce the risk of developing diabetes type 2 by 
50% [10].
How do we change the behavior of the population as 
a whole? It is our duty to inform the public about the 
relationships between obesity, poor physical activity, 
smoking, hypertension, and all other risk factors that 
may predispose one to developing type II diabetes. 
Unlike other chronic diseases, type II diabetes can be 
managed, and nearly eliminated with proper diet, ex-
ercise, treatment, and early detection. To that end, we 
must include screening programs that range from tar-
geted to opportunistic for our local population. Screen-
ing allows us to identify those who may be at risk (pre-
diabetic), and those that have been living with undiag-
nosed diabetes, in turn providing opportunity for early 
interventions. The residual effect of decreasing the in-
cidence of diabetes is astronomical. Not only would it 
reduce health care costs, it would dramatically reduce 
the prevalence of other chronic diseases. Cardiovascu-
lar disease is the leading cause of death in this country 
and 75% of cases have also been diagnosed with type 
II diabetes [11]. 
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Summary
Diabetes mellitus refers to a group of metabolic diseases that 
share the hallmark characteristic of hyperglycemia. Generally, 
Diabetes is categorized as type I, or type II. Type I results from 
the body’s failure to synthesize insulin, and requires insulin 
injections. Type II, also known as adult-onset or non-insulin 
dependent diabetes mellitus (NIDDM), occurs when the body’s 
cells fail to use insulin properly due to a defective insulin recep-
tor, and may also be combined with a relatively reduced insulin 
secretion. Type II can be managed with healthy lifestyle hab-
its and early detection of high sugar levels. Most local health 
departments across New York State offer hypertension screen-
ing but no pre-diabetes screening programs. The US preventive 
Services Task Force recommends that asymptomatic adults with 
sustained blood pressure greater than 135/80 mm Hg should be 
screened for type II diabetes. Since high blood sugar levels can 
be controlled, and in some cases reduced, there exist strong ben-
efits in offering pre-diabetic screening for individuals who are 
hypertensive. 
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Opportunistic screening
Several county health departments in New York current-
ly provide free blood pressure screenings at numerous 
locations throughout the county. The US preventive Ser-
vices Task Force  [12] recommends that asymptomatic 
adults with sustained blood pressure greater than 135/80 
mm Hg should be screened for type II diabetes. The 
American Diabetic Association has set forth guidelines 
for screening procedures; however these parameters 
can be adjusted for a local population and available re-
sources within a specific health network. Medicaid and 
Medicare cover diabetic testing, and by 2014, all insur-
ance plans are mandated to cover preventive services, 
of which diabetic screening would be included  [13, 
14]. The test of choice is the Fasting Plasma Glucose 
Test, it is inexpensive, and produces quick and repro-
ducible results. Clinical practice recommendations by 
the American Diabetic Association’s (ADA) Standards 
for Medical Care [15] deem fasted sugar levels greater 
than or equal to 126 mg/dL as diabetic, and anything 
between 100 to 125 mg/dL as pre-diabetic. Given the 
uncontrolled nature of health department visits and that 
at the time of visit an individual will most likely not be 
in a fasted state; the value of concern for a random blood 
glucose test is anything greater than 126 mg/dL. 
An individual that has a random blood glucose test re-
sult greater than 126 mg/dL should be scheduled for a 
fasted test, and proper action will be taken depending on 
the results of the second test. If the individual is found 
to be pre-diabetic upon subsequent testing they will be 
assigned to counseling to reduce their risk of develop-
ing diabetes. In addition, the ADA  [15] recommends 
follow up periods every three years for those who are 
pre-diabetic and over the age of 45. The time of onset 
of type II diabetes is not confirmed, but studies show 
that it is around ten years [16]. Therefore an individual 
who is pre-diabetic should be followed up, at minimum, 
for three to four screening periods (9-12 years). In most 
cases, those who are concerned enough about their live-
lihoods will learn to test their blood sugar a few times a 
month on their own. Medicaid and Medicare will cover 
the cost for home testing kits. Kits should also be avail-
able for purchase from the local health department at a 
subsidized cost for those who are uninsured or financial-
ly troubled. In the case that someone that is at risk has a 
negative result; an attempt should be made to re-screen 
them within six months. 
The assumption is that if one is warned of their risk of de-
veloping a disease that can be extremely debilitating the 
longer one has it; one will make changes in their lifestyle 
and behavior to avoid progression toward a clinically di-
agnosed state. Numerous programs and campaigns exist 
to promote these changes, such as Healthy New York, 
Healthy People 2020, and various programs at local 
YMCA’s. The first step, however, is to identify those 
who are at risk of having diabetes, those who are pre-di-
abetic. Since it is not feasible to screen the entire popu-
lation, the ADA recommends opportunistic screening to 
those who have one or more risk factors (Tab. I) [17]. In 
addition, a diabetes questionnaire should be completed 
by those who will be screened, with the assistance of 
a health care provider if needed, to supplement the test 
results [18].
To date, no trail has been done to determine if system-
atic screening and early treatment of pre-diabetics leads 
to improved health outcomes compared with clinical 
diagnosis. To conduct a randomized cohort clinical 
study would provide useful evidence to evaluate this 
proposal for diabetes screening. However, major hur-
dles exist. To provide diabetes screening to one group 
continuously for up to twelve years, and not to another, 
brings up ethical concerns that cannot be avoided [17]. 
In the case that many in the screened group are found 
to have diabetes, or pre-diabetes, these individuals may 
seek proper treatment or change lifestyle behaviors to 
prevent or extend their onset of clinical type II diabetes. 
Those in the non-screened group may continue to live 
with undiagnosed treatment, or would not be informed 
of their pre-diabetic state, and might continue to practice 
lifestyle habits which are detrimental to the avoidance of 
type II diabetes. 
Several state pilot projects that provide diabetes screen-
ing are underway across the country; and the results 
of a few studies have been published with remarkable 
results. The Diabetes Prevention Program that pro-
vides screening for people covered by Medicaid and 
Medicare in Minnesota showed an overall reduction of 
58% from pre-diabetes to diabetes type II. The state 
of Minnesota reported that they were able to deliver 
the Diabetes Prevention Program curriculum, for less 
than $300 per participant. This included screening, and 
16 lifestyle and health structured education sessions 
to those who were pre-diabetic  [19]. The Medicare 
Diabetes Screening Project  [20] in Georgia and New 
Hampshire has also reported great success by imple-
mentation of their own Diabetes Prevention Programs. 
Outside of the United States, the ADDITION (Anglo-
Danish-Dutch Study of Intensive Treatment in People 
with Screened Detected Diabetes in Primary Care), was 
a population based study that managed to achieve high 
levels of participant retention and follow up for over 
200,000 people between the ages of 40-69. The find-
Tab. I. risk factors for type 2 diabetes [16].
❏		Age ≥ 45 years
❏		Overweight (BmI ≥ kg/m2 *)
❏		Family history of diabetes (i.e., parents or siblings  
with diabetes)
❏		habitual physical inactivity
❏		race/ethnicity (e.g., African-Americans, hispanic-Americans, 
Native Americans, Asian-Americans, and pacific Islanders)
❏		previously identified IFT or IgT
❏		history of gdm or delivery of a baby weighing > 9 Ibs
❏		hypertension (≥ 140/90 mmhg in adults)
❏		hdL cholesterol ≤ 35 mg/dl (0.90 mmol/l) and/or a triglyceride 
level ≥ 250mg/dl (2.82 mmol/l)
❏		polycystic ovary syndrome
❏		history of vascular disease
* may not correct for all ethinic groups. BmI- Body mass index; gdm-ges-
tational diabetes mellitus;
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tive [22]. Providing this service from the health depart-
ment will promote and spread awareness of services and 
habits that will reduce the frequency of obesity, lack of 
physical activity, and poor diet. Overall, this program 
will provide a service that increases the general health 
and awareness of the community itself. Although the 
American Diabetic Association recommends screen-
ing with fasted blood glucose tests, it is not commonly 
performed in everyday clinical practice, even to indi-
viduals who shows many risk factors [23]. Thus, in the 
interest of the community, the public health service, 
namely the Department of Health, should take initia-
tive in a screening program. 
Providing screening for at risk individuals does not re-
quire any changes in the health infrastructure, and glu-
cose test kits are readily available at most health care 
facilities. It is highly likely that the incidence of type 
II will decrease through systematic screening. Since the 
screening will be opportunistic, and only offered to peo-
ple who fulfill one or more of the risk factors, resources 
will be well spent in this effort.
ings of the study were that “stepwise screening for type 
2 diabetes in primary care is feasible and acceptable 
[and] identifies individuals with high levels of modifi-
able risk factors [21]. 
Conclusion
The aim of this screening program is to identify those 
with undiagnosed diabetes and those who show signs 
of a pre-diabetic state. This will allow the health de-
partment to refer for early treatment or prevention to 
delay the onset of diabetes and the various other long-
term complications that are related with it. It is obvi-
ous that the economic costs of high blood sugar and its 
consequences are substantial. Although no real world 
studies have been done on the cost savings of screening 
versus no screening, several simulations have been run 
to determine if screening would be economically ef-
ficient. It has been shown that screening appears to be 
cost-saving and cost-neutral from a societal perspec-
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